Written by Michael L Roberts, PhD, Founder and CSO of Synpromics Published by MedNous, Evernow Publishing Ltd.

The past decade has seen a resurgence in the field of cell and gene therapy, with three treatments being approved by the European Medicines Agency and the US Food and Drug Administration and a flood of candidate therapies nearing the end of Phase 3 clinical trials, a number of which are demonstrating promising results.

Read the full article published by MedNous – download PDF.